← Leaderboards
David Andrew Largaespada
University Of Minnesota Twin Cities
$17,551,730
Attributed
$22,045,864
Total exposure
21
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,225,834 · 23
By mechanism
R01$13,186,979 · 8
U54$10,150,248 · 3
P01$9,378,487 · 1
P50$2,474,096 · 2
UH3$2,148,196 · 1
UG3$1,523,236 · 1
Top collaborators
- David J Odde17 shared
- Steven S Rosenfeld12 shared
- Nancy Ratner10 shared
- Robert T Cormier5 shared
- Adam J. Dupuy5 shared
- David Masopust5 shared
- Robert M Prins2 shared
- Julie Ann Ross2 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Robert T Cormier$1,599,553
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorMalignant NeoplasmsGeneticMutationGenesBaseGenetic ScreeningMouse ModelIn VivoPathway InteractionsCellsOncogenesNeoplasm MetastasisTumor ProgressionSleeping BeautyAnimalsLeadGrantMolecularAnimal ModelComplexProgramsCancer GeneticsIn Vitro
Grant awards (103)
Integrated Immune Engineering for Poor Prognosis Cancers$1,907,279
P01 · FY2025 · CA
Integrated Immune Engineering for Poor Prognosis Cancers$1,811,915
P01 · FY2024 · CA
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1$548,991
R01 · FY2024 · NS · contact PI
Integrated Immune Engineering for Poor Prognosis Cancers$1,869,132
P01 · FY2023 · CA
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention$770,000
UH3 · FY2023 · CA · contact PI
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1$571,785
R01 · FY2023 · NS · contact PI
Integrated Immune Engineering for Poor Prognosis Cancers$1,869,132
P01 · FY2022 · CA
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention$608,196
UH3 · FY2022 · CA · contact PI
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1$577,428
R01 · FY2022 · NS · contact PI
Integrated Immune Engineering for Poor Prognosis Cancers$1,921,029
P01 · FY2021 · CA
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention$770,000
UH3 · FY2021 · CA · contact PI
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1$582,915
R01 · FY2021 · NS · contact PI
Center for Modeling Tumor Cell Migration Mechanics$1,768,788
U54 · FY2020 · CA
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention$761,618
UG3 · FY2020 · CA · contact PI
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1$587,214
R01 · FY2020 · NS · contact PI
Core 2: Cell and Whole Animal Genome Engineering$40,293
U54 · FY2020 · CA · contact PI
Center for Modeling Tumor Cell Migration Mechanics$2,127,145
U54 · FY2019 · CA
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention$761,618
UG3 · FY2019 · CA · contact PI
Center for Modeling Tumor Cell Migration Mechanics$96,792
U54 · FY2019 · CA
Admin-Core-001$83,166
U54 · FY2019 · CA
Center for Modeling Tumor Cell Migration Mechanics$83,166
U54 · FY2019 · CA
Center for Modeling Tumor Cell Migration Mechanics$70,486
U54 · FY2019 · CA
Core 2: Cell and Whole Animal Genome Engineering$47,009
U54 · FY2019 · CA · contact PI
Core 2: Cell and Whole Animal Genome Engineering$13,828
U54 · FY2019 · CA · contact PI
Core 2: Cell and Whole Animal Genome Engineering$10,070
U54 · FY2019 · CA · contact PI
Center for Modeling Tumor Cell Migration Mechanics$1,868,789
U54 · FY2018 · CA
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance$496,936
R01 · FY2018 · NS · contact PI
Center for Modeling Tumor Cell Migration Mechanics$99,786
U54 · FY2018 · CA
Center for Modeling Tumor Cell Migration Mechanics$72,666
U54 · FY2018 · CA
Core 2: Cell and Whole Animal Genome Engineering$49,263
U54 · FY2018 · CA · contact PI
Center for Modeling Tumor Cell Migration Mechanics$1,756,806
U54 · FY2017 · CA
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance$491,889
R01 · FY2017 · NS · contact PI
Searching for Genetic Basis for Metastasis of Differentiated Thyroid Cancer$188,281
R21 · FY2017 · CA · contact PI
Core 2: Cell and Whole Animal Genome Engineering$62,538
U54 · FY2017 · CA · contact PI
Center for Modeling Tumor Cell Migration Mechanics$1,666,953
U54 · FY2016 · CA
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance$486,944
R01 · FY2016 · NS · contact PI
Sleeping Beauty for uncovering cancer genes in mice$251,592
R01 · FY2016 · CA · contact PI
Immunotherapeutic targeting of the Glioblastoma Mutanome$200,100
R21 · FY2016 · CA
Center for Modeling Tumor Cell Migration Mechanics$190,106
U54 · FY2016 · CA
Searching for Genetic Basis for Metastasis of Differentiated Thyroid Cancer$166,243
R21 · FY2016 · CA · contact PI
Core 2: Cell and Whole Animal Genome Engineering$42,598
U54 · FY2016 · CA · contact PI
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance$482,094
R01 · FY2015 · NS · contact PI
Sleeping Beauty for uncovering cancer genes in mice$251,795
R01 · FY2015 · CA · contact PI
Immunotherapeutic targeting of the Glioblastoma Mutanome$180,105
R21 · FY2015 · CA
Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance$490,339
R01 · FY2014 · NS · contact PI
A Genetic Screen for HCC Genes$293,831
R01 · FY2014 · CA · contact PI
Identifying and Targeting Pathways of Pancreatic Cancer Progression$261,150
P50 · FY2014 · CA · contact PI
Sleeping Beauty for uncovering cancer genes in mice$244,435
R01 · FY2014 · CA · contact PI
Discovery and Validation of Tumor Immunoevasion Mechanisms$176,610
R01 · FY2014 · CA · contact PI
Transposon-based screens for colorectal cancer genes$285,690
R01 · FY2013 · CA · contact PI
A Genetic Screen for HCC Genes$284,744
R01 · FY2013 · CA · contact PI
Identifying and Targeting Pathways of Pancreatic Cancer Progression$260,109
P50 · FY2013 · CA · contact PI
Sleeping Beauty for uncovering cancer genes in mice$237,060
R01 · FY2013 · CA · contact PI
Discovery and Validation of Tumor Immunoevasion Mechanisms$171,148
R01 · FY2013 · CA · contact PI
Mouse Genetics$115,165
P30 · FY2013 · CA · contact PI
Genetic Mechanisms of Cancer$69,349
P30 · FY2013 · CA · contact PI
Discovery and Validation of Tumor Immunoevasion Mechanisms$307,402
R01 · FY2012 · CA · contact PI
Transposon-based screens for colorectal cancer genes$303,925
R01 · FY2012 · CA · contact PI
A Genetic Screen for HCC Genes$302,919
R01 · FY2012 · CA · contact PI
Identifying and Targeting Pathways of Pancreatic Cancer Progression$282,664
P50 · FY2012 · CA · contact PI
Transposon-based Somatic Insertional Mutagenensis to Model NF-1$278,333
P50 · FY2012 · NS · contact PI
Sleeping Beauty for uncovering cancer genes in mice$252,382
R01 · FY2012 · CA · contact PI
Mouse Genetics$115,471
P30 · FY2012 · CA · contact PI
Genetic Mechanisms of Cancer$20,567
P30 · FY2012 · CA · contact PI
Mouse Genetics$2,678
P30 · FY2012 · CA · contact PI
Genetic Mechanisms of Cancer$2,678
P30 · FY2012 · CA · contact PI
Genetic Mechanisms of Cancer$1,776
P30 · FY2012 · CA · contact PI
Mouse Genetics$1,775
P30 · FY2012 · CA · contact PI
Transposon-based screens for colorectal cancer genes$303,925
R01 · FY2011 · CA · contact PI
A Genetic Screen for HCC Genes$302,919
R01 · FY2011 · CA · contact PI
Transposon-based Somatic Insertional Mutagenensis to Model NF-1$300,874
P50 · FY2011 · NS · contact PI
Identifying and Targeting Pathways of Pancreatic Cancer Progression$264,587
P50 · FY2011 · CA · contact PI
Mouse Genetics$128,496
P30 · FY2011 · CA · contact PI
Genetic Mechanisms of Cancer$22,885
P30 · FY2011 · CA · contact PI
A Genetic Screen for HCC Genes$325,038
R01 · FY2010 · CA · contact PI
Transposon-based screens for colorectal cancer genes$313,325
R01 · FY2010 · CA · contact PI
Identifying and Targeting Pathways of Pancreatic Cancer Progression$303,746
P50 · FY2010 · CA · contact PI
Sleeping Beauty for uncovering cancer genes in mice$257,668
R01 · FY2010 · CA · contact PI
Transposon-based Somatic Insertional Mutagenensis to Model NF-1$181,805
P50 · FY2010 · NS · contact PI
Mouse Genetics$137,867
P30 · FY2010 · CA · contact PI
Maternal dietary folic acid and risk of medulloblastoma in a mouse model$75,500
R03 · FY2010 · CA
Genetic Mechanisms of Cancer$24,554
P30 · FY2010 · CA · contact PI
Transposon-based screens for colorectal cancer genes$313,325
R01 · FY2009 · CA · contact PI
Sleeping Beauty for uncovering cancer genes in mice$257,668
R01 · FY2009 · CA · contact PI
Transposon-based Somatic Insertional Mutagenensis to Model NF-1$168,394
P50 · FY2009 · NS · contact PI
Mouse Genetics$133,949
P30 · FY2009 · CA · contact PI
Maternal dietary folic acid and risk of medulloblastoma in a mouse model$75,500
R03 · FY2009 · CA
Genetic Mechanisms of Cancer$23,857
P30 · FY2009 · CA · contact PI
Sleeping Beauty for uncovering cancer genes in mice$257,668
R01 · FY2008 · CA · contact PI
Transposon-based Somatic Insertional Mutagenensis to Model NF-1$172,434
P50 · FY2008 · NS · contact PI
Sleeping Beauty for uncovering cancer genes in mice$257,668
R01 · FY2007 · CA · contact PI
Transposon-based somatic mutagenesis/prostate cancer genetics$181,456
R21 · FY2007 · CA · contact PI
Sleeping Beauty for uncovering cancer genes in mice$262,727
R01 · FY2006 · CA · contact PI
Transposon-based somatic mutagenesis/prostate cancer genetics$203,830
R21 · FY2006 · CA · contact PI
Transposon Mutagenesis Development and Drug Abuse$314,796
R01 · FY2005 · DA
Transposon Mutagenesis Development and Drug Abuse$316,251
R01 · FY2004 · DA
Transposon Mediated Insertional Mutagenesis in Mice$327,891
R01 · FY2003 · DA
COOPERATING GENETIC EVENTS IN MYELOID LEUKEMIA DEVELOPME$238,965
R01 · FY2002 · CA
NF1 GENE IN MYELOID LEUKEMIA AND CYTOKINE SIGNALING$100,566
R29 · FY2002 · CA
COOPERATING GENETIC EVENTS IN MYELOID LEUKEMIA DEVELOPME$232,008
R01 · FY2001 · CA
NF1 GENE IN MYELOID LEUKEMIA AND CYTOKINE SIGNALING$97,310
R29 · FY2001 · CA
COOPERATING GENETIC EVENTS IN MYELOID LEUKEMIA DEVELOPME$225,069
R01 · FY2000 · CA
NF1 GENE IN MYELOID LEUKEMIA AND CYTOKINE SIGNALING$94,634
R29 · FY2000 · CA